SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on September 4, 2019. The registrant is an emerging growth company incorporated in California. The filing serves as a Regulation FD disclosure and notification of upcoming investor presentations.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate events rather than financial performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing discloses scheduled management presentations at three investment conferences in September 2019.
Guidance, Outlook, and Management Commentary
Management intends to present at the following events:
- 2019 Wells Fargo Healthcare Conference: September 4, 2019, in Boston, MA. Presented by CEO Will McGuire. A live webcast and 30-day archive are available.
- 4th Annual Dougherty & Company Institutional Investor Conference: September 5, 2019, in Minneapolis, MN. Presented by CFO John Blake via 1x1 meetings.
- H.C. Wainwright 21st Annual Global Investment Conference: September 9, 2019, in New York, NY. Presented by CEO Will McGuire.
The company explicitly disclaims any obligation to update the attached presentation materials (Exhibit 99.1) to reflect events occurring after the date of this report.
Investor Verification Checklist
- Verify the content of the attached presentation materials (Exhibit 99.1) for forward-looking statements.
- Confirm the availability of the archived webcast for the September 4 Wells Fargo conference on the company website.
- Note that the filing text does not contain updated financial results; refer to the most recent 10-Q or 10-K for financial data.